$153 Million is the total value of DCF Advisers, LLC's 67 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BRKB | New | BERKSHIRE HATHAWAY INC DELcl b new | $2,742,000 | – | 15,000 | +100.0% | 1.79% | – |
| GLD | New | SPDR GOLD TRUSTput | $2,591,000 | – | 17,500 | +100.0% | 1.70% | – |
| T | New | AT&T INCput | $2,492,000 | – | 85,500 | +100.0% | 1.63% | – |
| GDX | New | VANECK VECTORS ETF TRgold miners etf | $2,074,000 | – | 90,000 | +100.0% | 1.36% | – |
| CSCO | New | CISCO SYS INC | $1,278,000 | – | 32,500 | +100.0% | 0.84% | – |
| GDXJ | New | VANECK VECTORS ETF TRjr gold miners e | $984,000 | – | 35,000 | +100.0% | 0.64% | – |
| LOW | New | LOWES COS INC | $947,000 | – | 11,000 | +100.0% | 0.62% | – |
| IBM | New | INTERNATIONAL BUSINESS MACHS | $832,000 | – | 7,500 | +100.0% | 0.54% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $808,000 | – | 9,000 | +100.0% | 0.53% | – |
| HYG | New | ISHARES TRput | $732,000 | – | 9,500 | +100.0% | 0.48% | – |
| WBA | New | WALGREENS BOOTS ALLIANCE INC | $709,000 | – | 15,500 | +100.0% | 0.46% | – |
| ARNA | New | ARENA PHARMACEUTICALS INC | $693,000 | – | 16,500 | +100.0% | 0.45% | – |
| GM | New | GENERAL MTRS CO | $623,000 | – | 30,000 | +100.0% | 0.41% | – |
| JPM | New | JPMORGAN CHASE & CO | $450,000 | – | 5,000 | +100.0% | 0.29% | – |
| MSFT | New | MICROSOFT CORP | $394,000 | – | 2,500 | +100.0% | 0.26% | – |
| HYG | New | ISHARES TRcall | $347,000 | – | 4,500 | +100.0% | 0.23% | – |
| ADBE | New | ADOBE INC | $318,000 | – | 1,000 | +100.0% | 0.21% | – |
| KSS | New | KOHLS CORP | $255,000 | – | 17,500 | +100.0% | 0.17% | – |
| XLK | New | SELECT SECTOR SPDR TRput | $201,000 | – | 2,500 | +100.0% | 0.13% | – |
| OVV | New | OVINTIV INC | $57,000 | – | 21,000 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTRA-CELLULAR THERAPIES INC | 16 | Q3 2023 | 10.2% |
| MICRON TECHNOLOGY INC | 16 | Q3 2023 | 6.7% |
| ALPHABET INC | 16 | Q3 2023 | 5.8% |
| ABBVIE INC | 16 | Q3 2023 | 7.9% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 5.5% |
| ARGENX SE | 16 | Q3 2023 | 6.4% |
| SPDR GOLD TRUST | 16 | Q3 2023 | 6.6% |
| XENCOR INC | 16 | Q3 2023 | 4.1% |
| BK OF AMERICA CORP | 16 | Q3 2023 | 5.4% |
| ORACLE CORP | 16 | Q3 2023 | 3.2% |
View DCF Advisers, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-10 |
View DCF Advisers, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.